10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Gastrointestinal Stromal Tumors
3 articles
Extended Imatinib Therapy Slashes Recurrence Risk in High-Risk GIST Patients
Study shows 6 years of adjuvant imatinib significantly reduces relapse risk in high-risk GIST patients.
INSIGHT Trial: Tailoring GIST Treatment with Precision Medicine
New trial evaluates ripretinib vs sunitinib in advanced GIST patients with specific KIT mutations
Ripretinib Shows Promise in Chinese GIST Patients: Efficacy and Safety Comparable to Sunitinib
Phase 2 trial finds ripretinib effective and safer than sunitinib for advanced GIST in Chinese patients.